The duration of taking Tegretol after stenting is 1~2 years, and the exact duration of taking Tegretol should be decided according to the basic condition of the patient.
Most patients need to take Tegretol for anti-platelet aggregation therapy for at least 1 year after stenting, and 1 year after stenting is the time when blood clots are likely to form in the stent, and anti-platelet aggregation medication is needed for prevention at this time. Commonly used drugs are aspirin and Tegretol, which can usually be discontinued after 1 year.
Some patients are at risk for late-onset thrombosis, and the severity of the lesion needs to be monitored. If the patient belongs to the high risk of thrombosis and low risk of bleeding, then the time of taking Tegretol needs to be appropriately extended to 1.5 or even 2 years.
In the process of taking the drug, it is necessary to observe whether there is bleeding, the amount of bleeding, etc., and regularly go to the hospital to improve the coagulation function test, under the guidance of the doctor to use the drug.